Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Nuvalent, Inc. (NUVL)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 65,769,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Nuvalent is a biopharmaceutical company. Co.'s product candidate, NVL-520, is a ROS proto-oncogene 1 (ROS1)-selective inhibitor designed with the aim to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of available ROS1 tyrosine kinase inhibitors. Co.'s another product candidate, NVL-655, is a brain-penetrant anaplastic lymphoma kinase (ALK)-selective inhibitor, designed with the aim to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that may limit the use of first-, second-, and third-generation ALK inhibitors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 799,253
Total Buy Value $0 $0 $0 $26,774,976
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 1,132,833 1,374,179 1,588,071 1,862,739
Total Sell Value $82,196,365 $100,295,974 $110,820,634 $118,384,513
Total People Sold 5 7 8 8
Total Sell Transactions 12 21 47 78
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 150
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Shair Matthew   –       •      –    2024-04-22 4 AS $62.66 $2,386,910 D/D (37,500) 1,537,198     -
   Shair Matthew   –       •      –    2024-04-15 4 AS $65.27 $2,458,335 D/D (37,500) 1,574,698     -
   Conley Emily   –       •      –    2024-04-15 4 AS $65.52 $327,607 D/D (5,000) 8     -
   Conley Emily   –       •      –    2024-04-15 4 OE $9.36 $46,800 D/D 5,000 5,008     -
   Shair Matthew   –       •      –    2024-04-08 4 AS $67.89 $2,566,479 D/D (37,500) 1,612,198     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2024-04-04 4 AS $71.54 $220,787 D/D (3,000) 33,300     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2024-04-04 4 OE $6.89 $20,670 D/D 3,000 36,300     -
   Shair Matthew   –       •      –    2024-04-01 4 AS $76.82 $2,884,337 D/D (37,500) 1,649,698     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2024-03-28 4 AS $74.23 $1,654,311 D/D (22,000) 33,300     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2024-03-28 4 OE $18.93 $496,740 D/D 22,000 55,300     -
   Hack Andrew A. F.   –       •      –    2024-03-27 4 S $72.31 $64,035,959 I/I (880,000) 2,697,267     -
   Shair Matthew   –       •      –    2024-03-25 4 AS $76.74 $153,546 I/I (2,000) 238,522     -
   Shair Matthew   –       •      –    2024-03-25 4 AS $76.74 $2,878,982 D/D (37,500) 1,687,198     -
   Noci Darlene Chief Development Officer   •       –      –    2024-03-22 4 AS $77.25 $1,550,229 D/D (20,000) 33,300     -
   Noci Darlene Chief Development Officer   •       –      –    2024-03-22 4 OE $1.08 $154,800 D/D 20,000 53,300     -
   Conley Emily   –       •      –    2024-03-15 4 AS $79.81 $1,078,883 D/D (13,333) 8     -
   Conley Emily   –       •      –    2024-03-15 4 OE $9.36 $124,797 D/D 13,333 13,341     -
   Turner Christopher Durant Chief Medical Officer   •       –      –    2024-01-05 4 A $0.00 $0 D/D 33,300 47,813     -
   Porter James Richard President and CEO   •       •      –    2024-01-05 4 A $0.00 $0 D/D 112,800 188,113     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2024-01-05 4 A $0.00 $0 D/D 33,300 33,300     -
   Noci Darlene Chief Development Officer   •       –      –    2024-01-05 4 A $0.00 $0 D/D 33,300 33,300     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2024-01-05 4 A $0.00 $0 D/D 33,300 33,300     -
   Shair Matthew Director   –       •      –    2023-12-28 4 AS $75.20 $3,663,492 D/D (48,548) 1,724,698     -
   Shair Matthew Director   –       •      –    2023-12-27 4 AS $75.17 $75,170 D/D (1,000) 1,773,246     -
   Shair Matthew Director   –       •      –    2023-12-26 4 AS $74.22 $5,228,346 D/D (69,602) 1,774,246     -
  150 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us